Gist Weekly: May 31, 2024
Ozempic trial shows the drug slows kidney disease progression, a blood-based colorectal cancer test is endorsed for FDA approval, and nursing home trade groups sue over the new staffing mandate.
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Brief
Do you have questions about our products, consulting services, or overall solutions?